Interchem pharmaceutical company (Odessa) has launched a new laboratory and production complex for production of active pharmaceutical ingredients (API) in Odessa.
Interchem CEO Anatoliy Reder said during the celebrations dedicated to the company’s 25th anniversary, the launch of the new API production complex was the final stage of the investment program worth EUR50 million, being implemented since 2012.
Investments in the new API complex amounted to about EUR9 million.
Reder noted the opening of this complex would not bring money immediately, as it was an investment that would consolidate the company’s position on the market.
According to him, Interchem plans to use APIs produced at the new complex mainly for its own needs.
“Today we use about 85% of produced APIs for our own needs and sell about 15%, while we receive orders for some APIs from abroad. We are studying the possibilities of export,” he said.
Reder noted the equipment of the complex would fully ensure the implementation of environmental standards and requirements, completely excluding the possibility of contact of chemicals with the environment.
In addition, the equipment will allow producing finely dispersed APIs and small batches of substances. (Interfax-Ukraine/Business World Magazine)
